ProCE Banner Activity

Weight Gain and Cardiometabolic Toxicities in Patients With HIV

Podcast Episodes

Listen as Priscilla Y. Hsue, MD, and Jens D. Lundgren MD, DMSc, share their insights on applying the latest safety and tolerability data of HIV treatments in patients with cardiometabolic toxicities.

Released: October 04, 2022

Expiration: October 03, 2023

Share

Faculty

Priscilla Y. Hsue

Priscilla Y. Hsue, MD

Professor of Medicine
University of California at
San Francisco
San Francisco General Hospital
San Francisco, California

Jens D. Lundgren

Jens D. Lundgren, MD, DMSc

Professor
Rigshospital, University of Copenhagen
Director
Centre of Excellence for Health, Immunity and Infection (CHIP)
Rigshospital, University of Copenhagen
Copenhagen, Denmark

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from

Janssen Therapeutics, Division of Janssen Products, LP

ViiV Healthcare

Faculty Disclosure

Primary Author

Priscilla Y. Hsue, MD

Professor of Medicine
University of California at
San Francisco
San Francisco General Hospital
San Francisco, California

Priscilla Y. Hsue, MD: consultant/advisor/speaker: Gilead Sciences, Merck; researcher: Novartis.

Jens D. Lundgren, MD, DMSc

Professor
Rigshospital, University of Copenhagen
Director
Centre of Excellence for Health, Immunity and Infection (CHIP)
Rigshospital, University of Copenhagen
Copenhagen, Denmark

Jens D. Lundgren, MD, DMSc, has no relevant financial relationships to disclose.